Paid Clinical Trials in Horsham, PA
As of September 2026, 15 paid clinical trials are recruiting in Horsham, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Horsham offers studies at sites including Abington Medical Specialists for conditions such as Breast Cancer, Metastatic Breast Cancer, Obesity, Atherosclerotic Cardiovascular Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Horsham
Trials by drug in Horsham
Filter results
15 clinical trials
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Top Research Study Locations in Horsham
Researchers run research studies in Horsham, PA at 7 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Abington Medical Specialists | Obesity, Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease (ASCVD) | 3 |
| Alliance Cancer Specialists | Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer | 2 |
| Alliance Cancer Specialists, PC | Esophageal Adenocarcinoma, Gastroesophageal Junction Cancer, Metastatic Gastric Cancer | 2 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 2 |
| Alliance Cancer Specialists (ACS) | DLBCL, Diffuse Large B-Cell Lymphoma | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| USO - Alliance Cancer Specialists, PC | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | 1 |
Active & Upcoming Studies in Horsham (2026)
Recruiting trials in Horsham grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (7 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer · Phase 3 · Olema Pharmaceuticals, Inc.
Cardiovascular (4 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Diabetes & metabolic (2 active studies)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Common conditions studied in Horsham
- Breast Cancer (2 active studies)
- Metastatic Breast Cancer (2 active studies)
- Obesity (2 active studies)
- Atherosclerotic Cardiovascular Disease (1 active study)
- Atherosclerotic Cardiovascular Disease (ASCVD) (1 active study)
- Atrial Fibrillation (AF) (1 active study)
Leading research sponsors in Horsham
- AstraZeneca
- Amgen
- Eli Lilly and Company
- Pfizer
- Agendia
Frequently asked questions
How many paid clinical trials are currently recruiting in Horsham?
There are approximately 15 recruiting clinical trials in Horsham, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Horsham pay participants?
Most recruiting trials in Horsham compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Horsham?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Horsham?
The most common conditions under active study in Horsham include Breast Cancer (2), Metastatic Breast Cancer (2), Obesity (2), Atherosclerotic Cardiovascular Disease (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Horsham?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Horsham on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Horsham?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Horsham?
Recruiting research sites in Horsham include Abington Medical Specialists, Alliance Cancer Specialists, Alliance Cancer Specialists, PC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Horsham right now?
The largest active categories in Horsham are Cancer & tumors (7), Cardiovascular (4), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.